Please wait a minute...
Clinical and Experimental Obstetrics & Gynecology  2021, Vol. 48 Issue (3): 500-508    DOI: 10.31083/j.ceog.2021.03.2303
Original Research Previous articles | Next articles
Uterine receptor activation in response to uterotonic agents in late-pregnancy rat myometrium following pretreatment with oxytocin: an in vitro study
Li-Mei Liao1, Jian-Ying Hu1, Ting-Ting Wang1, Shao-Qiang Huang1, *()
1Department of Anaesthesia, Obstetrics & Gynecology Hospital, Fudan University, 200090 Shanghai, China
Download:  PDF(750KB)  ( 61 ) Full text   ( 7 )
Export:  BibTeX | EndNote (RIS)      
Abstract  
Background: Long term exposure to oxytocin reduces the ability of myometrium to respond to oxytocin, leading to oxytocin receptor (OXTR) desensitization. In this study we analyzed the response to other uterotonics such as prostaglandin, as well as investigating prostaglandin E2 receptors (EP3) and prostaglandin F2α receptors (FP). We hypothesized that compensatory mechanisms would increase the expression and activation of FP and EP3 following OXTR desensitization. Methods: Myometrium from late-pregnancy rats was collected in order to assess mRNA expression levels for OXTR, FP, and EP3 using RT-PCR. This was done after 2 hours of pretreatment with 10-6 M oxytocin to induce OXTR desensitization, or equilibration in physiological salt solution (PSS). Myometrium was exposed to increasing concentrations of uterotonic agents (10-10 to 10-5 M) following 2 hours of pretreatment with 10-6 M oxytocin (experimental group) or with PSS (control group). Myometrium from the experimental group was washed with PSS and OXTR expression was assessed using Western blot and RT-PCR. Results: mRNA expression levels for EP3, FP and OXTR were not statistically different between the experimental (OXTR desensitization) and control groups. Compared to the control group, the (mean ± SD) contractile potency of carboprost (pEC50: 7.74 ± 0.56 vs 6.81 ± 0.25, P = 0.03) and maximal contractility of misoprostol (Emax(ratio): 4.44 ± 3.60 vs 1.32 ± 0.22, P = 0.02) were significantly increased in the OXTR desensitization group, while the contractility of oxytocin was significantly reduced (Emax(ratio): 1.62 ± 0.27 vs 2.82 ± 0.98, P = 0.015). No significant differences in myometrial OXTR expression were observed between the PSS, carboprost and misoprostol groups following OXTR desensitization. Discussion: Following OXTR desensitization of myometrium, FP and EP3 activation increased in a compensatory manner, but not FP and EP3 receptor expression.
Key words:  Myometrial contraction      Oxytocin receptor      PGE receptor      PGF2α receptor      Uterotonics     
Submitted:  23 September 2020      Revised:  29 December 2020      Accepted:  07 January 2021      Published:  15 June 2021     
Fund: 
201840327/General Foundation of Shanghai Municipal Health Commission
*Corresponding Author(s):  Shao-Qiang Huang     E-mail:  drhuangsq@163.com

Cite this article: 

Li-Mei Liao, Jian-Ying Hu, Ting-Ting Wang, Shao-Qiang Huang. Uterine receptor activation in response to uterotonic agents in late-pregnancy rat myometrium following pretreatment with oxytocin: an in vitro study. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(3): 500-508.

URL: 

https://ceog.imrpress.com/EN/10.31083/j.ceog.2021.03.2303     OR     https://ceog.imrpress.com/EN/Y2021/V48/I3/500

[1] Kumari Anukriti, Kiran Guleria, Vipin Tyagi, Amita Suneja, B D Banerjee. Maternal blood and amnionic oxytocin receptor gene expression and serum oxytocin levels in preterm birth: a case-control study[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(2): 283-291.
[2] H.A. Mansouri, D. Bahkali. A randomized controlled trial of intra-umbilical vein ergometrine as compared to intramuscular oxytocin for management of third stage of labor[J]. Clinical and Experimental Obstetrics & Gynecology, 2018, 45(4): 567-569.
No Suggested Reading articles found!